The Dangers of Smoking Hookah, E-cigarettes and Vaping

Aug.02.2022
The Dangers of Smoking Hookah, E-cigarettes and Vaping
Waterpipe smoking is just as harmful as cigarette smoking, containing addictive nicotine and known carcinogens. Electronic cigarettes also pose health risks.

Numerous studies indicate that many of the chemicals found in cigarette smoke are also present in hookah smoke.


Evidence suggests that the oily liquid used in electronic cigarettes can cause other lung diseases such as lipoid pneumonia and bronchitis.


Like smoking, hookah contains addictive nicotine.


Lung cancer is becoming a major healthcare challenge in India, with over 10,000 new cases expected in the next five years. It is more prevalent in males (accounting for around 70% of cases) but the incidence rate among females has been steadily increasing over the past decade.


Lung cancer has several risk factors, with the main one being smoking, which accounts for 90% of lung cancer cases. However, some people believe that smoking hookah is a safer and more social alternative to smoking, and does not pose any health risks. Dr. Vishesh Gumdal, an oncologist consultant at the LB Nagar Hyderabad American Cancer Society, has debunked this myth and highlighted some significant health risks associated with it.


Chemicals found in cigarette smoke are also present in waterpipes.


Dr. Gumdal explains that a hookah is a type of smoking device that uses a mixture of tobacco and various flavors to produce smoke. The mixture is heated with charcoal and the smoke is then filtered through a water-filled container before being inhaled by the user through a hose with a mouthpiece.


Although some may believe that the toxicity of hookah smoking is less harmful than traditional cigarette smoking, numerous studies have shown that many chemicals found in cigarette smoke are also present in hookah smoke. More than 50 known carcinogens have been found in hookah smoke. Like cigarettes, hookah contains addicting nicotine. In summary, hookah smoking is just as detrimental as traditional smoking.


The oily liquid used when vaping e-cigarettes can lead to other lung diseases.


Apart from hookah, other smoking technologies such as e-cigarettes can also lead to severe lung diseases. Dr. Gumdal explains that vapor involves the process of heating substances and inhaling the resulting smoke. Devices such as "e-cigarette pens" or "mods" are typically used to heat substances in liquid form until smoke is produced.


He added, "Many of these liquid mixtures contain a variety of flavorings, fragrances, nicotine, and cannabis derivatives. These mixtures are often dissolved in oily alkaline substances. Toxic chemicals such as formaldehyde, acrylonitrile and diacetyl are also inhaled. Many of these chemicals are carcinogenic.


However, there is little scientific evidence linking electronic cigarettes to lung cancer. Part of the reason may be that even in Western countries, these habits are relatively new for people, and it would take decades of research and follow-up on people addicted to this practice to establish a causal relationship between e-cigarettes and lung cancer.


He said that considering the presence of toxic chemicals in the liquids used in e-cigarettes, in his view, over time, more scientific data may link these practices to lung cancer. There is evidence that the oily liquids used in e-cigarettes can cause other lung diseases such as lipoid pneumonia, bronchitis (or popcorn lung), and spontaneous pneumothorax. Therefore, it is best to be safe and avoid addiction to these practices until further research is completed.


Shisha usage is prevalent among young people.


Electronic cigarettes have been completely banned in India since 2019. However, there is currently no national law prohibiting water pipes, which is especially concerning given more scientific evidence linking them to lung disease and lung cancer.


Experts claim that the younger generation is increasingly using hookah due to Western influence on our culture. Commercial establishments offering hookah services seem to be particularly concentrated around many urban educational institutions.


Of particular concern is the widespread use of hookah among young people in India. While there have been some recent improvements in regulations around hookah, parents and guardians must remain vigilant in monitoring their children's use. Schools and other educational institutions should also be encouraged to place a greater emphasis on educating students about the harmful effects of hookah.


Statement:


This article is compiled from third-party information and is intended solely for industry exchange and learning.


This article does not represent the views of 2FIRSTS and we cannot confirm the truthfulness or accuracy of the content. The translation of this article is intended solely for industry exchange and research.


Due to limited translation skills, the translated article may not fully express the original meaning. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in all domestic, Hong Kong/Macau/Taiwan-related, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11